Artificial Intelligence

Formerly Pure Harvest, Mixie Technologies acquires a stake in digital twin firm HoloTwin, signaling a major strategic shift into AI and platform solutions.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

From innovative liquid-cooled LCDs to premium laser TVs with Google TV, Formovie's latest projectors signal a major play for the entire home cinema market.

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.

With a massive $200M Series C, Soley Therapeutics is using its AI cell-sensing platform to fast-track novel cancer drugs from code to clinic.

Freshworks appoints Kady Srinivasan, a proven growth leader from Lightspeed and Klaviyo, as CMO to spearhead its AI-first strategy in the competitive SaaS market.

With its revolutionary Prime Editing tech showing promise, Prime Medicine faces a pivotal moment at the J.P. Morgan conference. Can it justify its new strategy?

With a device that calms deadly 'cytokine storms,' SeaStar Medical targets vast new markets, but can the small company deliver on its huge promises?

At CES 2026, TCL unveiled its X11L TV with 10,000 nits brightness, alongside AI robots and AR glasses, signaling a major push beyond the screen.

NRG Energy names insider Robert J. Gaudette as its next CEO, signaling strategic continuity as the energy giant navigates a market in transformation.

Kelonia Therapeutics gets the FDA green light to expand trials for its in vivo CAR-T therapy, a single-infusion treatment that could redefine cancer care.

Azitra will present its novel AI-driven skin therapies for rare diseases at Biotech Showcase, seeking crucial funding and partnerships to advance its pipeline.

As its SPAC merger with Churchill Capital IX nears, PlusAI will meet investors at a key conference, showcasing its autonomous trucking tech and strategy.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

A new alliance aims to replace painful biopsies with high-res biology, mapping organ rejection at the cellular level to usher in a new era of personalized care.

The newly formed food tech giant will outline its strategic priorities, with investors closely watching for synergy updates and future growth plans.

Southeast Asian legal tech innovators are targeting the lucrative U.S. market, but face a minefield of IP risks. Here's how they're preparing to win.

Pharma giant Bayer partners with AI innovator Cradle, betting on generative AI to accelerate its biologics pipeline and reshape modern medicine.